Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Hepion Pharmaceuticals's cash was $4.26M at Sep 30, 2026. For fiscal 2025 it was $1.83M, up 349.8% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $91.35M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.83M | +349.8% |
| FY2024 | Dec 31, 2024 | $406.41K | -97.3% |
| FY2023 | Dec 31, 2023 | $14.79M | -71.1% |
| FY2022 | Dec 31, 2022 | $51.19M | -44.0% |
| FY2021 | Dec 31, 2021 | $91.35M | +124.3% |
| FY2020 | Dec 31, 2020 | $40.73M | +192.5% |
| FY2019 | Dec 31, 2019 | $13.92M | +7.2% |
| FY2017 | Jun 30, 2017 | $12.98M | +75.3% |
| FY2016 | Jun 30, 2016 | $7.40M | +62.3% |
| FY2015 | Jun 30, 2015 | $4.56M | +151.0% |
| FY2014 | Jun 30, 2014 | $1.82M | +1996.2% |
| FY2013 | Jun 30, 2013 | $86.72K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $4.26M | +83.3% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $1.63M | -44.3% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $2.60M | -43.3% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $1.83M | +349.8% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $2.32M | +55.0% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $2.92M | +38.3% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $4.59M | -65.0% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $406.41K | -97.3% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $1.50M | -92.2% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $2.12M | -93.1% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $13.11M | -69.5% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $14.79M | -71.1% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $19.28M | -67.4% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $30.52M | -57.4% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $42.99M | -45.7% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $51.19M | -44.0% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $59.15M | -40.1% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $71.71M | -34.9% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $79.22M | -31.4% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $91.35M | +124.3% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $98.73M | +620.1% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $110.09M | +526.9% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $115.45M | +619.4% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $40.73M | +192.5% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $13.71M | -7.8% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $17.56M | +2.4% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $16.05M | +853.7% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $13.92M | +7.2% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $14.86M | +142.2% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $17.15M | +62.5% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $1.68M | -44.4% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $12.98M | +75.3% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $6.14M | +3.0% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $10.55M | +7.3% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $3.03M | +69.1% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $7.40M | +62.3% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $5.96M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $9.83M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $1.79M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $4.56M | – |
See a number that looks wrong?